Related Experiment Video
Updated: Jan 26, 2026
15:03
Building a Better Mosquito: Identifying the Genes Enabling Malaria and Dengue Fever Resistance in A. gambiae and A. aegypti Mosquitoes
Published on: July 4, 2007
11.3K
[Management of uncomplicated malaria]
1Service des maladies infectieuses et tropicales, groupe hospitalier Sud-Île de France. Inserm, IPLESP, Sorbonne Université, UMRS-1136, Paris, France.
La Revue Du Praticien
|April 16, 2019
Summary
Artemisinin-based combination therapies are now the first-line treatment for uncomplicated Plasmodium falciparum malaria. Prompt diagnosis and close follow-up are crucial for effective management, whether inpatient or outpatient.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Parasitology
Background:
- Malaria, particularly Plasmodium falciparum, is a severe imported tropical illness.
- Fever in travelers from endemic regions necessitates malaria suspicion.
- Updated 2017 care guidelines are essential for management.
Purpose of the Study:
- To outline the current management strategies for uncomplicated malaria.
- To highlight diagnostic approaches and treatment recommendations.
- To define criteria for outpatient versus hospital-based care.
Main Methods:
- Diagnosis relies on thin/thick blood films or rapid diagnostic tests (results within 2 hours).
- Treatment recommendations updated in 2017.
- Clinical and biological follow-up at days 3, 7, and 28 is specified.
Main Results:
- Artemisinin derivative-based combinations are the recommended first-line treatment.
- These therapies offer rapid action and high effectiveness.
- Criteria for outpatient management are established.
Conclusions:
- Prompt diagnosis and appropriate treatment are key for uncomplicated malaria.
- Artemisinin-based combinations represent a significant advance in malaria treatment.
- Careful patient selection and follow-up enable safe outpatient management.
More Related Videos
Related Concept Videos
01:26Tonsillitis II: Management
417
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
417
01:29Impression Management Techniques I: Managing Appearances
207
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
207
01:19Management of Insomnia
580
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
580
01:19Managing Impressions
169
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
169
01:24Cystic Fibrosis: Management
489
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
489
01:26Angina IV: Management
276
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
276